cabozantinib,atezolizumab
roche
['contact-03', 'congrat', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'cabozantinib']
contact-03: adding atezolizumab to cabozantinib adds toxicity (safety&amp;financial) in 2nd line #rcc without pfs or os benefit #asco23 congrats to for answering this important question 
Professor of Urology, Chairman Department of Urology, EiC "Aktuelle Urologie", Editor World Journal of Urology. Chairman EUSP, EAU-Board Member